Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 02 March 2021 5:05 pm

Almost 20.5m Brits have received the first dose of a Covid-19 vaccine

By: Tom Saunders

Add as a preferred source on Google
Almost 20.5 million Brits have received the first dose of the COVID-19 vaccine.

Nearly 20.5m Brits have been given their first dose of the Covid-19 vaccine, according to official data released by the ONS.

The successful vaccine rollout in the UK, where Brits are offered a first dose and then a second jab 12 weeks later, is translating into a greater share of the population having some protection from the virus.

Official data also showed a further 6,391 cases and 343 deaths within 28 days of a positive Covid-19 test. In the last seven days, 53,761 people have tested positive for Covid, down almost 30 per cent from the week before that.

Deaths within 28 days of a positive test were also down 36 per cent compared to the week before.

This week the health secretary announced that a single injection of either the Astrazeneca/Oxford jab or the Pfizer/Biontech vaccine is more than 80 per cent effective in preventing hospitalisation among over-80s.

In the US, Johnson & Johnson has agreed to partner with its long-time competitor, Merck, to produce its single-shot vaccine in a deal that was brokered by the White House. The Johnson & Johnson vaccine is the third to be approved for use in the United States, with regulators still withholding approval of the AstraZeneca vaccine.

Merck scrapped two coronavirus vaccine candidates in January after vaccine shots failed to produce an immune response in early trials. Merck already produces vaccines for the  Ebola virus, HPV, and hepatitis B.

Read more

UK debt ‘hits £3 trillion’ milestone

Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Vaccine

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Brits dodge the high street as heatwave boosts online shopping

    Retail
    Shoppers carrying various retail bags, including New Look and M&S Food, on a paved street, indicating retail sales activity.
  • Burnham says Infantino ‘wrong man’ to lead Fifa as Brits back World Cup boycott plans

    Sport Business
    Andy Burnham speaking at a podium with microphones, gesturing with his hands, crowd in background
  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • England World Cup final run could see Brits spend extra £250m

    Sport Business
    Breaking news conference with business leaders discussing economic strategies, panelists seated at table with microphones.
  • Brits think supermarkets are profiteering – despite slowing food inflation

    Retail
    Shopper with red backpack and blue basket walking through a supermarket aisle filled with groceries
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Brits wary of EU summer hols as officials refuse to ease new border checks

    Transport & Infrastructure
    Airport delays in Spain
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook